Baumer S.A. operates in the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Baumer S.A. with three other
medical equipment manufacturers in developing countries:
Woojung BIO Inc
of KOREA (SOUTH)
sales of 37.34 billion Korean Won [US$31.59 million]
of which 89%
was infection control),
Health&Life Co Ltd
(774.16 million Taiwanese Dollars [US$27.88 million]
Corentec Co Ltd
based in KOREA (SOUTH)
(40.50 billion Korean Won [US$34.26 million]
of which 48%
was THR Finished Product).
Sales levels dropped significantly in the second
quarter of 2021 versus the previous year's second quarter.
During the second
quarter of 2021, sales at Baumer S.A. totalled
29.80 million Brazilian Reals.
This is a drop of 38.7%
from the 48.59 million Brazilian Reals in sales at the company during the second quarter in 2020.
This was the biggest quarterly decline in sales at Baumer S.A. in the previous 35 quarters.
During the first two
quarters of 2021, sales totalled 63.16 million Brazilian Reals, which is
than through the first two quarters of 2020.
Baumer S.A. reported sales of 162.97 million Brazilian Reals (US$30.81 million)
December of 2020.
increase of 9.2%
versus 2019, when the company's sales were 149.31 million Brazilian Reals.
This was the third consecutive year of growth at Baumer S.A..